SNS Yohimbine 2.5

Serious Nutrition Solutions Yohimbine HCL 2.5mg 100 Caps

Increase Fat Loss & Metabolism

If you suffer from those pesky stubborn body fat areas usually the love handles and midsection for men & the thighs & glutes in women. By increasing the bloodflow to these stubborn areas it allows the body to free up stored fatty acids and use them as energy. Yombine can also be used for enhancing mood, and libido and sex drive in men and women!

Serious Nutrition Solutions Yohimbine HCL Highlights

• Helps With Fat Loss, Energy, and Appetite Control
• Supports Enhanced Sex Drive & Libido
• Contains 2.5mg of Yohimbine HCL Per Capsule
• Often Used for Erectile Dysfunction
• Helps Boost Athletic Performance and Endurance

What is Yohimbine Used For?

• Erectile Dysfunction
• Boost Libido
• Energy
• Appetite Suppression

Why is Yohimbine Banned in Some Countries?

Yohimbine is legal and perfectly fine to use and order in the United States, if you are in another country please check your countries laws and customs rules prior to ordering. The reason Yohimbine is banned in some countries is due to less scrupulous brands inaccurate product labeling and dosing which can potentially cause side effects. Yohimbine is banned in some countries like Australia, Canada, and the UK.

Directions

Take 1 capsule up to 3 times per day.

Serious Nutrition Solutions Yohimbine HCL 2.5mg Supplement Facts

Serving Size: 1 Capsule

Servings Per Container: 100

Yohimbine HCL 2.5mg

Other Ingredients: Gelatin, Maltodextrin, Magnesium Stearate, Silicon Dioxide.

Warnings

This product should only be used by those 18 years old and up. Consult a physician prior to use.

References

Kucio C, Jonderko K, Piskorska D. Does yohimbine act as a slimming drug? Isr J Med Sci. 1991 Oct;27(10):550-6. PMID: 1955308.

https://pubmed.ncbi.nlm.nih.gov/1955308/

Akhondzadeh S, Amiri A, Bagheri AH. Efficacy and Safety of Oral Combination of Yohimbine and L-arginine (SX) for the Treatment of Erectile Dysfunction: a multicenter, randomized, double blind, placebo-controlled clinical trial. Iran J Psychiatry. 2010;5(1):1-3.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430403/